A nurse who started a charity from a granny flat in her parent’s backyard to reduce hospital waste has taken out one of the Australian nursing profession’s most prestigious honours.
Brisbane’s Claire Lane MACN was today named the 2022 winner of the Health Minister’s Award for Nursing Trailblazers, a national award recognising nurses whose leadership has led to innovative solutions addressing key challenges facing our health and aged care systems.
Claire received the award for her work with Save our Supplies, a for-purpose organisation that collects excess clean usable medical supplies from hospitals.
Working with Rotary, they redirect the supplies to areas of need, including developing nations, war-torn areas like Ukraine and Flood impact regions of Australia.
The announcement was made at the Australian College of Nursing (ACN) National Nursing Forum in Darwin by Assistant Minister for Health and Aged Care Ged Kearney.
ACN CEO Adjunct Professor Kylie Ward FACN congratulated Claire on becoming the fourth nurse – and third successive from Queensland – to win the Health Minister’s Award for Nursing Trailblazers.
“Claire is an exceptional woman and nurse who has used her leadership, expertise and passion for social impact – characteristics our profession prides itself on – to make the world and future a better place,” Adjunct Professor Ward said.
“She not only created an innovative solution to address one of the biggest challenges facing our healthcare systems, but has gone above and beyond to use it to improve the health of people across the world.
“She exemplifies the mission of the Health Minister’s Award for Nursing Trailblazers, showcasing to Australians the leading role nurses’ skills and expertise play in shaping the lives of those we care for.
Assistant Minister Ged Kearney noted the honour she felt as a nurse to announce the recipient of the Health Minister’s Award for Nursing Trailblazers. She also reflected on “how proud she was to have been a nurse” and that she wanted “every single nurse to be proud of what you do every day for all Australians”.
-
Understanding extracellular vesicles in cancer therapy research
Joy Wolfram is an Associate Professor at the Australian Institute for Bioengineering and Nanotechnology and the School of Chemical Engineering at the University of Queensland in Australia. Originally from Finland, she earned both her bachelor’s and master’s degrees in biology before transitioning to engineering with a PhD in nanotechnology completed in China. Wolfram has over a decade of experience working in hospitals in the United States before joining the University of Queensland.
Her research focuses on extracellular vesicles, which are crucial for cell communication both locally within tissues and over longer distances between organs. Her lab studies the roles of these vesicles in both health and disease, particularly in cancer. They investigate the harmful messages released by cancer cells that aid in tumour growth, specifically in breast cancer, while also exploring how to harness beneficial extracellular vesicles from healthy individuals as potential therapeutics.
-
Smart wearable technology recognised for improving quality of life
Nurses have a pivotal role to play in the widespread implementation and adoption of digital health technologies throughout the healthcare sector for the primary purpose of improving safety and quality of patient care.
Australian Health Journal talked to two of Australian top leaders in nursing and in digital health on how the role of nursing is pivotal to the success of digital health in the Australian health system.
-
Developing the nation’s first Health and Medical Research Strategy
Professor Steve Wesselingh serves as the CEO of NHMRC, having initially trained as an infectious diseases doctor. His career includes prominent roles such as Head of the Infectious Diseases Unit at the Alfred Hospital, Director of the Burnett, Dean of Medicine at Monash University, and the inaugural Director of SAHMRI. Under his leadership, NHMRC plays a critical role in funding health and medical research, allocating approximately a billion dollars annually to investigator-led projects, clinical trials, and various strategic initiatives. NHMRC also collaborates internationally with organisations such as the MRC and the EU, and manages grant allocation for the MRFF, which distributes $650 million each year.
